Philip Tsai
Chief Technical Officer · Immunome Inc.
IndividualBuying only
- 2024
- Jul 27, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Philip Tsai files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Isaac Barchas - $9.94M in IMNM purchases and sales in the last 12 months
- Max Rosett - $2.52M in IMNM purchases and sales in the last 12 months
- Robert Lechleider - $2.34M in IMNM purchases and sales in the last 12 months
- Kinney Horn - $2.30M in IMNM purchases and sales in the last 12 months
- Philip Wagenheim - $1.34M in IMNM purchases and sales in the last 12 months
- Jean Jacques Bienaime - $555K in IMNM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Philip Tsai?
Philip Tsai is a corporate insider, tracked as Chief Technical Officer of Immunome Inc. (IMNM). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Philip Tsai submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Philip Tsai been buying or selling stock?
Recorded transactions: 1 open-market purchase ($198K) and 0 open-market sales across all tracked filings.
